参加编写论著： 1． Pyykkö I, Zou J, Gürkov R, Naganawa S, Nakashima T. Imaging of Temporal Bone. A Lea J, Pothier D (eds): Vestibular Disorders. Adv Otorhinolaryngol. Basel, Karger, 2019, vol 82, pp 12-31. https://doi.org/10.1159/000490268. 2． Focal Drug Delivery in Inner Ear Therapy：Focal Controlled Drug Delivery. Springer, London, UK. ISBN: 978-1-4614-9433-1 (Print) 978-1-4614-9434-8 (Online), 2014, 总字数：. 3． Noise-related hearing impairment. Genes, Hearing and Deafness: From Molecular Biology to Clinical. Edited by Alessandro Martini,Dafydd Stephens,and Andrew P. Read，published by Informa Healthcare, London, 2007-07. ISBN-10: 0415383595, ISBN-13: 9780415383592. 4． 自身免疫性感音神经性听力减退，《现代自身免疫病学》孔海云主编，人民军医出版社,北京,1996年7月1日. ISBN: 9787800206429. 共647页. 5． 梅尼埃病，《现代自身免疫病学》孔海云主编，人民军医出版社,北京,1996年7月1日. ISBN: 9787800206429. 共647页. 6． 《临床鼻科学》王荣光主编， 河北科学技术出版社,石家庄, 1995年6月1日.  ISBN: 9787537513968. 共318页. 获奖及获得专利情况(第一完成人) 2018年：因“基于听觉保存与重建关键技术的听神经瘤治疗策略及应用”获得国家科技进步二等奖（第八完成人）(证书号：2018-J-253-2-05-R08)。 2000年: 因“感音神经性聋的免疫相关研究”获军队科技进步二等奖(第一完成人)。 2019年：一种骨粉收集与清洗装置，实用新型专利（ZL 2018 2 1268552.0）。 2019年：一种可膨胀不吸收的适形外耳道术后填塞管装置，实用新型专利（ZL 2017 2 1032585.0）。 2018年：一次性显微外科手术吸引头，实用新型专利 （201721238170.9）。 2018年：一种软头鼓室吸引喷药针，实用新型专利 （201721665246.6）。 2018年：一种可拆卸式骨颗粒制备与采集装置，实用新型专利 （201720923128.4）。 2016年：一种治疗外周性眩晕的低频振动源与乳突之间的耦合装置，发明专利（ZL 2015 1 0246855.7）。 2015 年：一种治疗梅尼埃病的低频剪切应激振动装置，发明专利(ZL 2013 10 166642.2) 2014年：一种安全鼓室操作导管，实用新型专利(ZL 2013 2 0548546.1)。 2013年：一种靶向性微创内耳持续微量药物投放装置, 实用新型专利（ZL 2013 2 0058328. X）。 2006年:2004-2005年度上海交通大学医学院附属新华医院科研工作先进个人。 2003年:国家发明专利,专利名称为外加电场蛋白快速吸附仪,专利号为ZL 99 1 19099.8,国际专利主分类号为G01N 33/53,专利权人为邹静。 2013年：因“一种治疗酶尼埃病的低频剪切应激振动装置”获得教育部国际合作与发展司举办的“春晖杯”中国留学人员创新创业大赛优胜奖。 1995年: 因“V型胶原的提取及其与梅尼埃病相关研究”获军队科技进步三等奖(第一完成人)。 发表的主要论文（共150篇，*通讯作者107篇） SCI(79，*通讯作者48 篇)： 1. Zou J*, Zhao Z, Song X, Zhang G, Li H, Zhang Q, Pyykkö I. Elevated G-CSF, IL8, and HGF in patients with definite Meniere’s disease may indicate the role of NET formation in triggering autoimmunity and autoinflammation. Sci Rep. 2022 Sep 29;12(1):16309. doi: 10.1038/s41598-022-20774-8. 2. Pyykkö I, Pyykkö N, Zou J, Manchaiah V. Does the Self-training in Ménière's Disease Fit the Disease Characteristics and Help Alleviate the Balance Problems? J Int Adv Otol. 2022 Jan;18(1):25-31. doi: 10.5152/iao.2022.21205. 3. Zou J*, Chen L, Li H, Zhang G, Pyykkö I, Lu J. High-quality imaging of endolymphatic hydrops acquired in 7 minutes using sensitive hT2W-3D-FLAIR reconstructed with magnitude and zero-filled interpolation. Eur Arch Otorhinolaryngol. 2022 May;279(5):2279-2290. doi: 10.1007/s00405-021-06912-4. Epub 2021 Jun 18. 4. Kutlubaev MA*, Xu Y, Manchaiah V, Zou J, Pyykkö I.Vestibular drop attacks in Ménière's disease: A systematic review and meta-analysis of frequency, correlates and consequences. J Vestib Res. 2021 Apr 28. doi: 10.3233/VES-201514. Online ahead of print. 5. Ahmad A, Rilla K, Zou J, Zhang W, Pyykkö I, Kinnunen P, Ranjan S*. Enhanced gene expression by a novel designed leucine zipper endosomolytic peptide. Int J Pharm. 2021 May 15;601:120556. doi: 10.1016/j.ijpharm.2021.120556. Epub 2021 Mar 30. 6. Wang P, Yu D, Wang H, Ye H, Qiao R, Chen Z, Wu Y, Li Y, Shi H*, Zou J, Yin S. Contrast-Enhanced MRI Combined With the Glycerol Test Reveals the Heterogeneous Dynamics of Endolymphatic Hydrops in Patients With Menière's Disease. J Magn Reson Imaging. 2020 Mar 11; 52(4): 1066-1073. doi: 10.1002/jmri.27127. IF=3.954 7. Gürkov R*, Barath K, de Foer B, Fukushima M, Gluth M, Hornibrook J, Perez-Fernandez N, Pyykkö I, Sone M, Usami SI, Wang W, Zou J, Naganawa S. A plea for systematic literature analysis and conclusive study design, comment on: "Systematic review of magnetic resonance imaging for diagnosis of Meniere disease". J Vestib Res. 2019 Jun 6. doi: 10.3233/VES-190662. [Epub ahead of print]. IF=2.8158 8. Gürkov R*, Sousa RF, Zou J, Barath K. Insufficient image quality. J Neurol. 2019 Aug;266(8):2068-2069. doi: 10.1007/s00415-019-09354-5. 9. Zhang G, Zheng H, Pyykko I, Zou J*. The TLR-4/NF-κB signaling pathway activation in cochlear inflammation of rats with noise-induced hearing loss. Hear Res. 2019 May 3;379:59-68. doi: 10.1016/j.heares.2019.04.012. IF=3.76 10. Pyykkö I*, Manchaiah V, Zou J, Levo H, Kentala E. Driving Habits and Risk of Traffic Accidents among People with Ménière's Disease in Finland. J Int Adv Otol. 2019 Aug;15(2):289-295. doi: 10.5152/iao.2019.5915. IF=0.8479 11. Pyykkö I*, Manchaiah V, Zou J, Levo H, Kentala E. Association between Syncope and Tumarkin Attacks in Ménière's Disease. J Int Adv Otol. 2019 Apr;15(1):135-140. doi: 10.5152/iao.2019.6094. IF=0.8479 12. Pyykkö I*, Manchaiah V, Färkkilä M, Kentala E, Zou J. Association between Ménière's disease and vestibular migraine. Auris Nasus Larynx. 2019 May 1. pii: S0385-8146(18)30812-5. doi: 10.1016/j.anl.2019.02.002. [Epub ahead of print]. IF=2.5 13. Yang S, Zhu H, Zhu B, Wang H, Chen Z, Wu Y, Chen B, Shi H*, Li Y*, Zou J*, Yin S. Correlations Between the Degree of Endolymphatic Hydrops and Symptoms and Audiological Test Results in Patients With Menière's Disease: A Reevaluation. Otol Neurotol. 2018;39(3):351-356. doi: 10.1097/MAO.0000000000001675. IF=2.063 14. Pyykkö I*, Manchaiah V, Zou J, Levo H, Kentala E. Vestibular syncope: A disorder associated with drop attack in Ménière's disease. Auris Nasus Larynx. 2018; 45:234-241. doi: 10.1016/j.anl.2017.03.023. IF=2.5 15. Pyykkö I*, Manchaiah V, Zou J, Levo H, Kentala E. Impact of Tumarkin attacks on complaints and work ability in Meniere’s disease. Journal of Vestibular Research.  2018;28(3-4):319-330. doi: 10.3233/VES-180634. 16. Pyykkö I*, Manchaiah V, Zou J, Levo H, Kentala E. Relational quality, illness interference, and partner support in Ménière's disease. Int J Audiol. 2018 Jan;57(1):69-75. doi: 10.1080/14992027.2017.1367847. 17. Manchaiah V*, Pyykkö I, Zou J, Levo H, Kentala E. Patient-reported benefits from patient organization magazines and Internet-based peer support in Ménière's disease. Patient Prefer Adherence. 2017 Oct 26;11:1851-1857. doi: 10.2147/PPA.S142257. eCollection 2017. 18. Zhao Z*, Min M, Gu X, Zheng H, Qiu J, Jing Zou J*. Coexistence and mutual regulation between tyrosine hydroxylase and calcitonin gene-related peptide in facial nucleus of rats regulate the neuronal activities of afferent and efferent neuro fibers. Int J Clin Exp Med 2017;10(6):9073-9080. 19. Zou J*, Ostrovsky S, Israel LL, Feng H, Kettunen MI, Lellouche JP, Pyykkö I. Efficient Penetration of Ceric Ammonium Nitrate Oxidant-stabilized Gamma-maghemite Nanoparticles through the Oval and Round Windows into the Rat Inner Ear as Demonstrated by MRI. J Biomed Mater Res Part B. 2017; 105(7):1883-91. doi: 10.1002/jbm.b.33719. IF= 3.373 20. Senn P, Roccio M, Hahnewald S, Frick C, Kwiatkowska M, Ishikawa M, Bako P, Li H,  Liu W, Rask-Andersen H, Pyykko I, Zou J, Mannerstrom M, Keppner H, Homsy A, Laux E, Llera M, Lellouche JP, Ostrovsky S, Banin E, Gedanken A, Perkas N, Wank U, Wiesmüller KH, Mistrík P, Benav H, Garnham C, Jolly C, Gander F, Ulrich P, Müller M, Löwenheim H. NANOCI-Nanotechnology Based Cochlear Implant With Gapless Interface to Auditory Neurons. Otol Neurotol. 2017 Sep;38(8):e224-e231. doi: 10.1097/MAO.0000000000001439. 21. Zou J*, Feng H, Sood R, Kinnunen PKJ, Pyykko I. Biocompatibility of Liposome Nanocarriers in the Rat Inner Ear After Intratympanic Administration. Nanoscale Res Lett. 2017 Dec;12(1):372. doi: 10.1186/s11671-017-2142-5. IF= 3.159 22. Pyykkö I, Manchaiah V, Zou J, Levo H, Kentala E. Do patients with Ménière's disease have attacks of syncope? J Neurol 2017; 264 (Suppl 1): S48–S54. doi: 10.1007/s00415-017-8452-9. IF=6 23. Gurkov R*, Pyyko I, Zou J, Kentala E. What is Meniere's disease? A contemporary re-evaluation of endolymphatic hydrops. J Neurol. 2016; 263 Suppl 1, pp S71-S81. 24. Mannerström M*, Zou J, Toimela T, Pyykkö I, Heinonen T. The applicability of conventional cytotoxicity assays to predict safety/toxicity of mesoporous silica nanoparticles, silver and gold nanoparticles and multi-walled carbon nanotubes. Toxicol In Vitro. 2016 Dec;37:113-120. doi: 10.1016/j.tiv.2016.09.012. IF=5.0 25. Pyykkö I*, Zou J, Schrott-Fischer A, Glueckert R, Kinnunen P. An Overview of Nanoparticle Based Delivery for Treatment of Inner Ear Disorders. Methods Mol Biol. 2016;1427:363-415. doi: 10.1007/978-1-4939-3615-1_21. 26. Bondarenko OM*, Heinlaan M, Sihtmäe M, Ivask A, Kurvet I, Joonas E, Jemec A, Mannerström M, Heinonen T, Rekulapelly R, Singh S, Zou J, Pyykkö I, Drobne D, Kahru A. Multilaboratory evaluation of 15 bioassays for (eco)toxicity screening and hazard ranking of engineered nanomaterials: FP7 project NANOVALID. Nanotoxicology. 2016 Nov;10(9):1229-42. doi: 10.1080/17435390.2016.1196251. IF=11.5 27. Feng H, Pyykkö I, Zou J*. Involvement of Ubiquitin-Editing Protein A20 in Modulating Inflammation in Rat Cochlea Associated with Silver Nanoparticle-Induced CD68 Upregulation and TLR4 Activation. Nanoscale Res Lett. 2016 Dec;11(1):240. doi: 10.1186/s11671-016-1430-9. IF= 3.159 28. Zou J*, Pyykkö I. Calcium Metabolism Profile in Rat Inner Ear Indicated by MRI after Tympanic Medial Wall Administration of Manganese Chloride. Annals of Otology, Rhinology & Laryngology. 2016 Jan;125(1):53-62. pii: 0003489415597916. 29. Zou J*, Hannula M, Lehto K, Feng H, Lähelmä J, Aula AS, Hyttinen J, Pyykkö I. X-ray microtomographic confirmation of the reliability of CBCT in identifying the scalar location of cochlear implant electrode after round window insertion. Hearing Research. 2015 Apr 25;326:59-65. doi: 10.1016/j.heares.2015.04.005. 30. Zou J*, Lähelmä J, Koivisto J, Dhanasingh A, Jolly C, Aarnisalo A, Wolff J, Pyykkö I. Imaging the cochlear implantation with round window insertion in human temporal bones and cochlear morphological variation using high-dimensional cone beam CT. Acta Oto-Laryngologica. 2015 May;135(5):466-72. doi: 10.3109/00016489.2014.993090. 31. Zou J*, Hannula M, Misra S, Feng H, Labrador R, Aula AS, Hyttinen J, Pyykkö I. Micro CT visualization of silver nanoparticles in the middle and inner ear of rat and transportation pathway after transtympanic injection. J Nanobiotechnology. 2015 Jan 27;13(1):5. doi: 10.1186/s12951-015-0065-9. IF= 5.294. 32. Zou J*, Pyykkö I. Enhanced oval window and blocked round window passages for middle-inner ear transportation of gadolinium in guinea pigs with a perforated round window membrane. Eur Arch Otorhinolaryngol. 2015;272(2):303-9. 33. Ahmad A, Ranjan S, Zhang W, Zou J, Pyykkö I, Kinnunen PK. Novel endosomolytic peptides for enhancing gene delivery in nanoparticles. Biochim Biophys Acta. 2015;1848(2):544-53. 34. Zou J*, Koivisto J, Lähelmä J, Aarnisalo A, Wolff J, Pyykkö I. Imaging optimization of temporal bones with cochlear implant using a high- resolution cone beam CT and the corresponding effective dose. Annals of Otology, Rhinology & Laryngology. 2015 Jun;124(6):466-73. doi: 10.1177/0003489414565004. 35. Feng H, Pyykkö I, Zou J*. Hyaluronan up-regulation is linked to renal dysfunction and hearing loss induced by silver nanoparticles. Eur Arch Otorhinolaryngol. 2015; 272(10):2629-42. doi: 10.1007/s00405-014-3213-1. 36. Zou J*, Feng H, Mannerström M, Heinonen T, Pyykkö I. Toxicity of silver nanoparticle in rat ear and BALB/c 3T3 cell line. Journal of Nanobiotechnology. 2014 Dec 3;12(1):52. doi: 10.1186/s12951-014-0052-6. IF= 5.294. 37. Zou J*, Sood R, Zhang Y, Kinnunen PKJ, Pyykkö I. Pathway and morphological transformation of liposome nanocarriers after release from a novel sustained inner-ear delivery system. Nanomedicine (Lond). 2014; 9(14):2143-55. IF= 5.824. 38. Shi H, Li Y, Yin S*, Zou J*. The predominant vestibular uptake of gadolinium through the oval window pathway is compromised by endolymphatic hydrops in Meniere’s disease. Otology & Neurotology, 2014;35(2):315-22. 39. Zhen M, Zheng J, Wang Y, Shu C*, Gao F, Zou J*, Pyykkö I, Wang C*. Multifunctional Nanoprobe for MRI/Optical Dual-Modality Imaging and Radical Scavenging. Chemistry-- A European Journal. 2013;19:14675-81 40. Zou J*, Zhang Y, Zhang W, Poe D, Zhai S, Yang S, Pyykkö I. Mitochondria toxin-induced acute cochlear cell death indicates cellular activity-correlated energy consumption. Eur Arch Otorhinolaryngol. 2013; 270:2403-15. 41. Pyykkö I, Nakashima T, Yoshida T, Zou J, Naganawa S. Ménière’s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualization of endolymphatic hydrops. BMJ Open. 2013; 3(2): e001555. 42. Zou J*, Sood R, Ranjan S, Poe D, Ramadan UA, Pyykkö I, Kinnunen PKJ. Size dependent passage of liposome nanocarriers with preserved post-transport integrity across the middle-inner ear barriers in rats. Otology & Neurotology, 2012;33(4):666-73. 43. Zhang Y, Zhang W, Johnston AH, Newman TA, Pyykkö I, Zou J*. Targeted delivery of Tet1 peptide functionalized polymersomes to the rat cochlear nerve. Int J Nanomedicine, 2012;7:1015-22. 44. Surovtseva EV, Johnston AH, Zhang W, Zhang Y, Kim A, Murakoshi M, Wada H, Newman TA, Zou J, Pyykkö I. Prestin binding peptides as ligands for targeted polymersome mediated drug delivery to outer hair cells in the inner ear. Int J Pharm. 2012;424(1-2):121-7. 45. Zou J*, Poe D, Ramadan UA, Pyykkö I. Oval window transports Gd-DOTA from the rat middle ear to the vestibulum and scala vestibuli shown by in vivo MRI. Ann Otol Rhinol Laryngol. 2012, 121: 119-128 46. Zhang Y, Zhang W, Johnston AH, Newman TA, Pyykkö I, Zou J*. Comparison of the distribution pattern of PEG-b-PCL polymersomes delivered into the rat inner ear via different methods. Acta Otolaryngol. 2011;131(12):1249-56. 47. Pyykkö I, Zou J, Zhang W, Zhang Y. Nanoparticle-based delivery for the treatment of inner ear disorders. Curr Opin Otolaryngol Head Neck Surg 2011;19:388-96. 48. Zou J*, Yoshida T, Ramadan UA, Pyykkö I. Dynamic Enhancement of the Rat Inner Ear after Ultra-Small-Volume Administration of Gd-DOTA to the Medial Wall of the Middle Ear Cavity. ORL J Otorhinolaryngol Relat Spec. 2011;73(5):275-281. 49. Zhang W, Zhang Y, Löbler M, Schmitz KP, Ahmad A, Pyykkö I, Zou J*. Nuclear entry of hyperbranched polylysine nanoparticles into cochlear cells. Int J Nanomedicine. 2011; 6:535-46. IF= 5.115. 50. Zhang W, Zhang Y, Sood R, Ranjan S, Surovtseva E, Ahmad A, Kinnunen P KJ, Pyykkö I, Zou J*. Visualization of intracellular trafficking of Math1 protein in different cell types with a newly constructed nonviral gene delivery plasmid. J Gene Med 2011; 13:134-44. 51. Zou J*, Li M, Zhang Y, Zheng G, Chen D, Chen S, Zheng H. Transport Augmentation through the Blood-Inner Ear Barriers of Guinea Pigs Treated with 3-Nitropropionic Acid and Patients with Acute Hearing Loss, Visualized with 3.0 T MRI. Otology & Neurotology 2011, 32:204-212. 52. Zhang Y, Zhang W, Löebler M, Schmitz LP, Saulnier P, Perrier T, Pyykkö I, Zou J*. Inner ear biocompatibility of lipid nanocapsules after round window membrane application. International Journal of Pharmacology. 2011, 404:211-219. 53. Zou J*, Sood R, Ranjan S, Poe D, Ramadan UA, Kinnunen PKJ, Pyykkö I. Manufacturing and in vivo inner ear visualization of MRI traceable liposome nanoparticles encapsulating gadolinium. Journal of Nanobiotechnology, 2010, 8:1-11. 54. Zou J*, Zhang W, Poe D, Qin J, Fornara A, Zhang Y, Ramadan UA, Muhammed M, Pyykkö I. MRI manifestation of novel SPIONs in rat inner ear. Nanomedicine (UK). 2010; 5: 739-754. IF= 5.982. 55. Pyykkö I, Zou J, Poe D, Nakashima T, Naganawa S. Magnetic resonance imaging of the inner ear in Meniere's disease. Otolaryngol Clin North Am. 2010 Oct;43(5):1059-80. doi: 10.1016/j.otc.2010.06.001. Review. 56. Zhang Y, Zhang W, Johnston AH, Newman TA, Pyykkö I, Zou J*. Improving the visualization of autofluorescently tagged nanoparticles and fluorophore-labeled molecular probes by treatment with CuSO4 to quench autofluorescence in the rat inner ear. Hearing Research. 2010; 269:1-11. 57. Zou J*, Ramadan UA, Pyykko I. Gadolinium uptake in the rat inner ear perilymph evaluated with 4.7 T MRI: a comparison between transtympanic injection and gelatin sponge-based diffusion through the round window membrane. Otology Neurotology. 2010; 31: 637-641. 58. Zou J*, Zhang W, Poe D, Zhang Y, Ramadan UA, Pyykkö I. Differential passage of gadolinium through the mouse inner ear barriers evaluated with 4.7T MRI. Hear Res. 2010; 259: 36-43. 59. Keisala T, Minasyan A, Lou YR, Zou J, Kalueff AV, Pyykkö I, Tuohimaa P. Premature aging in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol. 2009;115: 91-7. IF=5.011 60. Minasyan A, Keisala T, Zou J, Zhang Y, Toppila E, Syvälä H, Lou YR, Kalueff AV, Pyykkö I, Tuohimaa P. Vestibular dysfunction in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol. 2009;114 161-6. IF=5.011 61. Zou J*, Poe D, Bjelke B, Pyykko I. Visualization of inner ear disorders with MRI in vivo: from animal models to human application. Acta Otolaryngol Suppl. 2009;(560):22-31. Review. 62. Zou J*, Zhang Y, Yin S, Wu H, Pyykkö I. Mitochondrial dysfunction disrupts trafficking of Kir4.1 in spiral ganglion satellite cells. Journal of Neuroscience Research 2009, 87(1):141-9. 63. Zou J*, Asukas J, Inha T, Laine A,Topilla E,Kellomäki M, Pyykkö I. Biocompitibility of diferent biopolymers after being implanted into the rat cochlea. Otology Neurotology 2008，29(5):714-9. 64. Zou J*, Saulnier P, Perrier T, Zhang Y, Manninen T, Toppila E, Pyykkö I. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation. Journal of Biomedical Materials Research: Part B-Applied Biomaterials. 2008， 87(1):10-8. 65. Zou J*, Minasyan A, Keisala T, Zhang Y, Wang J, Lou Y, Kalueff A, Pyykkö I, Tuohimaa P. Progressive Hearing Loss in Mice with a Mutated Vitamin D Receptor Gene. Audiology & Neurotology 2008， 13(4):219-30. 66. Pyykkö I, Zou J. Do viruses cause inner ear disturbances? ORL J Otorhinolaryngol Relat Spec. 2008， 70(1):32-40; discussion 40-1. 67. Lü J, Zou J, Wu H, Cai L. Compensative Shuttling of Merlin to Phosphorylation on Serine 518 in Vestibular Schwannoma. The Laryngoscope 2008， 118(1):169-74. 68. Sutinen P, Zou J, Hunter LL, Toppila E, Pyykko I. Vibration-Induced Hearing Loss: Mechanical and Physiological Aspects. Otol Neurotol. 2007; 28(2): 171-177. 69. Sutinen P, Toppila E, Starck J, Brammer A, Zou J, Pyykko I. Hand-arm vibration syndrome with use of anti-vibration chain saws: 19-year follow-up study of forestry workers. Int Arch Occup Environ Health. 2006; 79(8): 665-71. 70. Regala C, Duan M, Zou J, Salminen M, Olivius P. Xenografted fetal dorsal root ganglion, embryonic stem cell, and adult neural stem cell survival following implantation into the adult vestibulocochlear nerve. Experimental Neurology 2005；193：326-333. 71. Zou J*, Pyykkö I, Bjelke B, Dastidar P, Toppila E. Communication between the perilymphatic scalae and spiral ligament visualized by in vivo MRI. Audiology & Neuro-Otology 2005；10：145-152. 72. Zou J*, Pyykkö I, Sutinen P, Toppila E. Vibration Induced Hearing Loss in Guinea Pig Cochlea: Expression of TNF- α and VEGF. Hearing Research 2005；202：13-20. 73. Counter SA, Zou J, Bjelke B, Klason T. 3D MRI of the in vivo vestibulo-cochlea labyrinth during Gd-DTPA-BMA uptake. NeuroReport 2003;14:1707-1712. 74. Zou J*, Pyykko I, Counter SA, Klason T, Bjelke B. In vivo observation of dynamic perilymph formation using 4.7 T MRI with gadolinium as a tracer. Acta Otolaryngol (Stockholm) 2003;123:910-915. 75. Zou J*, Ilmari Pyykkö, Poul Bretlau, Tomas Klason, Börje Bjelke. In vivo visualization of endolymphatic hydrops in guinea pigs: MRI evaluation at 4.7 T. Annals of otology, rhinology and laryngology.2003;112:1059-1065. 76. Zou J*, Bretlau P, Pyykkö I, Toppila E, Olovius NP, Stephanson N, Beck O, Miller JM. Comparison of the protective efficacy of neurotrophins and antioxidants for vibration-induced trauma. ORL - Journal for Oto-Rhino-Laryngology. 2003 ;65:155-161. 77. Zou J*, Bretlau P, Pyykkö I, Starck J, Toppila E. Sensorineural hearing loss after vibration: an animal model for evaluating prevention and treatment of inner ear hearing loss. Acta Oto-Laryngologica (Stockholm) 2001; 121:143-148. 78. Zou J*, Jiang S, Gu R. An observation on otoacoustic emission and ultrastructure of cochlea in experimental autoimmune inner ear disease. Chinese Medical Journal 1996;109(8):639-644. 79. Peng Z*，Shang Y，Zou J，Wu Y，Ren G， Wang H，Wang Z，Wang M，Fu S. Approaches and reconstruction in skull base operation. Chinese Medical Journal, 1996; 109 (9): 700-704. 其他期刊（71篇，*通讯作者60篇）： 1． Zou J*, Zhao Z, Li H, Zhang G, Zhang Q, Lu J, Pyykkö I. Dexamethasone does not affect endolymphatic hydrops (EH) in patients with Meniere’s disease within 24 h, and intratympanic administration of gadolinium plus dexamethasone simplifies high-quality imaging of EH using a novel protocol of 7 minutes. Journal of Otology 2022; 17:164-174. DOI: https://doi.org/10.1016/j.joto.2022.02.002 2． Zou J*, Zhao Z, Zhang G, Zhang Q, Pyykkö I. MEFV, IRF8, ADA, PEPD, and NBAS gene variants and elevated serum cytokines in a patient with unilateral sporadic Meniere's disease and vascular congestion over the endolymphatic sac. Journal of Otology 2022; 17:175-181. DOI: https://doi.org/10.1016/j.joto.2022.03.001 3． Pyykkö I, Pyykkö N, Zou J, Manchaiah V. Characterization of Balance Problems and Rehabilitation Needs of Patients with Ménière's Disease. Audiol Res. 2022 Jan 5;12(1):22-32. doi: 10.3390/audiolres12010003. 4． 邹静*，王武庆，戴春富，时海波，刘爱国，陈录广，李跃华，潘初，胡颖，陆建平，吴皓. 钆增强MRI检测梅尼埃病内淋巴积水的技术与临床应用. 中华耳 鼻咽喉头颈外科杂志2020; 55（9）: 869-877. 5． Zou J*. Missing perilymph but leaking blood-endolymph and vestibulocochlear nerve barriers in idiopathic sudden sensorineural hearing loss: a case study. Journal of Otology 2020, 15(4): 171–173. 6． 邹静*, 陈录广, 陈玉坤, 王振, 张国平, 李鸿彬, 张晶, 喻国宁, 张涛, 郑宏良, 陆建平. 3 T 高清RS-EPI DWI与SS-EPI DWI序列诊断中耳胆脂瘤的效果比较. 中华耳科学杂志2020; 18: 80-87. 7． Zou J*, Wang Z, Chen Y, Zhang G, Chen L, Lu J. MRI detection of endolymphatic hydrops in Meniere's disease in 8 minutes using MIIRMR and a 20-channel coil after targeted gadolinium delivery. World J Otorhinolaryngol Head Neck Surg 2020;5(4):180-187. doi: 10.1016/j.wjorl.2019.04.001. 8． Zou J*. Autoinflammatory characteristics and short-term effects of delivering high-dose steroids to the surface of the intact endolymphatic sac and incus in refractory Ménière's disease. J Otol. 2019 Jun;14(2):40-50. doi: 10.1016/j.joto.2019.01.001. 9． 邹静*, 王振, 陈玉坤, 张国平, 陆建平, 郑宏良. 鼓室内侧壁后上部投放微量钆喷酸葡胺及重T2加权三维液体衰减反转恢复序列优化在检测内淋巴积水中的应用. 中华耳鼻咽喉头颈外科杂志 2018；53(12):931-938. 10． 张国平，邹静*. 耳蜗炎症反应在噪声性耳聋中的作用机制. 中华耳科学杂志2018; 16(12):701-5. 11． 邹静*, 秦晶, 姜晓瑜, 李勇, 周蓉珏, 徐菲, Timo Hirvonen, Antti Aarnisalo, Jussi Jero, 郑宏良.芬兰人工耳蜗植入术加强无菌措施的方法. 中华耳科学杂志2018; 16(1): 118-21. 12． Zou J*, Hirvonen T. “Wait and scan” management of patients with vestibular schwannoma and the relevance of non-contrast MRI in the follow-up. Review Article. Journal of Otology 2017; 12(4):  174-184 13． Zou J*, Peng B, Ostrovsky S, Li B, Li C, Kettunen MI, Lellouche JP, Pyykkö I. Biological effect tetra-branched anti-TNF-peptide and coating ratio-dependent penetration of the peptide-conjugated Cerium3/4+ Cation-stabilized gamma-maghemite nanoparticles into rat inner ear after transtympanic injection visualized by MRI. Journal of Materials Science & Nanotechnology 2017, 5(2):1-8. ISSN: 2348-9812 14． 邹静*. 钆增强 MRI 检测内淋巴积水的研究进展. 听力学与言语疾病杂志. 2017; 25(1): 75-85 15． Zou J*, Lähelmä J, Aarnisalo A, Pyykkö I. Clinically relevant human temporal bone measurements using novel high-resolution cone-beam CT. Journal of Otology, 2017, 12(1): 9-17. 16． Zou J*, Pyykko I, Hyttinen J. Inner ear barriers to nanomedicine-augmented drug delivery and imaging. Journal of Otology, 2016, 11(4): 165-177 17． Zou J*, Isomaki A, Hirvonen T, Aarnisalo A, Jero J, Pyykko I. Label-free visualization of cholesteatoma in the mastoid and tympanic membrane using CARS microscopy. Journal of Otology, 2016; 11: 127-133. DOI: http://dx.doi.org/10.1016/j.joto.2016.09.001. 18． Zou J*, Duan X, Zheng G, Zhao Z, Chen S, Dai P, Zheng H. A novel PIK3CD C896T mutation detected in bilateral sudden sensorineural hearing loss using next generation sequencing: An indication of primary immunodeficiency. Journal of Otology, 2016; 11: 78-83. doi:10.1016/j.joto.2016.06.001. 19． Zou J*. Postaurical injection is a systemic delivery supported by symmetric distribution of Gd-DOTA in both the ipsilateral and contralateral ears. Journal of Otology. 2015; 10(4): 136-142. 20． Zou J*, Feng H, Pyykko I. TLR signaling pathway regulation in association with autophagy in the diseased inner ear. J J Mol Transl Med. 2015, 1(1): 008. 21． Zou J*, Ostrovsky S, Israel LL, Lellouche JP, Pyykkö I. Targeted delivery of contrast agents to the tympanic medial wall at minimum amount and the efficient uptake in the inner ear through oval and round windows. Austin Journal of Radiology. 2015; 2(6): 1034. 22． Zou J*, Pyykkö I, Yoshida T, Gürkov R, Shi H, Li Y, Zheng G, Zhao Z, Peng R, Zheng H, Yin S, Hyttinen J, Nakashima T, Naganawa S. Milestone research on Meniere’s disease by visualizing endolymphatic hydrops using gadolinium-enhanced inner ear MRI and the challenges in clinical applications. Austin Journal of Radiology. 2015; 2(6): 1035. 23． Zou J*, Peng R, Zheng G, Zhang Q, Toppila E, Zheng H, Pyykko I. Improvement in the inner ear symptoms of patients with Meniere's disease after treatment using low-frequency vibration: a preliminary report. Edorium Journal of Otolaryngology  2015; 2: 5-13,  http://www.edoriumjournalofotolaryngology.com/archive/early_view_articles/005_O04_2015010002_OA_EV.pdf. 24． 邹静*，郑宏良，高颖娜，彭日顺子，郑贵亮. 圆窗和卵圆窗加固术治疗外伤性上半规管骨折. 听力学及言语疾病杂志2015; 23(4): 351-354. 25． 彭日顺子,  郑贵亮,  张青,  郑宏良, 邹静*. 低频旋转乳突振动对正常志愿者听力的影响. 中华耳科学杂志2015年第13卷第1期, 53-58. 26． Zou J*, Zheng G, Peng R, Gao Y, Chen S, Zheng H. Collision injury-induced superior semicircular canal fracture and therapeutic effect of round and oval window reinforcements. Edorium Journal of Otolaryngology 2014;1:11–17. Article ID: 100002JZO042014 doi:10.5348/o04-2014-3-CR-3. 27． Zou J*, Pyykkö I. Outcomes of endolymphatic shunt surgery in Ménière's disease indicate potential contribution of shear stress instead of relieving the endolymphatic hydrops. Otolaryngology 2014, 4:3. doi:10.4172/2161-119X.1000171 28． Pyykkö I*, Zou J, Zhang Y, Zhang W, Feng H, Kinnunen P. Nanoparticle based inner ear therapy. World J Otorhinolaryngol 2013; 3: 114-133. 29． 王毅*; 刘志明; 邹静; 习国平. 鼻内窥镜手术中结缔组织生长因子表达的意义. 中华全科医学, 2014年 第02期, 230-232+333 30． Zou J*, Pyykko I. Endolymphatic hydrops in Meniere’s disease secondary to otitis media and visualized by gadolinium-enhanced magnetic resonance imaging. World J Otorhinolaryngol. 2013; 3: 22-25. 31． Pyykkö I*, Selmani Z, Zou J. Low-frequency sound pressure and transtympanic endoscopy of the middle ear in assessment of "spontaneous" perilymphatic fistula. ISRN Otolaryngol. 2012;2012:137623. doi: 10.5402/2012/137623 32． 邹静*，Ilmari Pyykkö. 内淋巴囊手术治疗梅尼埃病与剪切应激反应. 中华耳科学杂志2012; 10 (2): 255-259. 33． 王毅*; 刘志明; 邹静; 习国平; 张运波; 赖春红. 结缔组织生长因子在鼻息肉中的分布和表达. 中国耳鼻咽喉头颈外科, 07期, pp 378-380, 2011. 34． Poe D, Zou J*, Zhang W, Qin J, Abo Ramadan U, Fornara A, Muhammed M, Pyykkö I., MRI of the Cochlea with Superparamagnetic Iron Oxide Nanoparticles Compared to Gadolinium Chelate Contrast Agents in a Rat Model. Europ. J. nanomed., 2009. 2: p. 29-36. 35． Zou J*, Zhang Y, Zhang W, Ranjan S, Sood R, Mikhailov A, Kinnunen P, Pyykko I. Internalization of liposome nanoparticles functionalized with TrkB ligand in rat cochlear cell populations. European Journal of Nanomedicine 2009; 3:8-14. 36． Pyykkö I*, Zou J, Kentala E, Stephens D. Tinnitus treatment – are drugs effective? Audiological Medicine, 2008;6:25-39 37． Zou J*, Pyykko I, Bjelke B, Toppila E. In vivo MRI visualization of endolymphatic hydrops induced by keyhole limpet hemocyanin round window immunization. Audiological Medicine 2007; 5(3): 182-87. 38． 张亚, 邹静*, Ilmari Pyykko, 吴皓. 线粒体毒素诱导伴有眩晕的突发性耳聋模型的建立.上海交通大学学报（医学版）2007; 27(1):14-18. 39． 吕静荣，邹静*，吴皓.激光聚焦显微镜同步呈现听神经瘤单个细胞周期蛋白与merlin. 上海交通大学学报（医学版）2007; 27(1):19-21. 40． 邹静*, Pyykkö I, Sutinen P, Toppila E. 耳蜗振动创伤后血迷路屏障变化的磁共振成像表现. 中华耳科学 2006; 4 (1): 61-64. 41． 吕静荣，邹静*，吴皓. Merlin蛋白在听神经瘤组织中的表达与分布.中华耳鼻咽喉头颈外科杂志 2006 Jul;41(7):501-5. 42． Zou J*, Zhang Y, Pyykkö I, Wu H. An Animal Model of Sudden Onset Sensorineural Hearing Loss with Vestibular Function Disturbances Induced By Mitochondrial Toxin. Journal of Otology 2006; 1(2): 86-93. 43． Zou J*, Pyykko I, Bjelke B, Counter SA. 豚鼠外源性血管内皮细胞生长因子增强内耳屏障转运作用的磁共振成像研究. 中华耳鼻咽喉头颈外科杂志. 2005;40(4):266-70. 44． Zou J*, Pyykko I, Bjelke B. 用MRI体内观测钥孔嘁血蓝素中耳免疫诱导的内淋巴积水的初步探讨. 中华耳科学 2005; 3: 200-203. 45． 邹静*，毕爱芳，杨伟炎，周永青，丁卫东，郝晓东.中耳细菌感染对内耳及机体免疫功能长期影响的实验观察. 中华耳鼻咽喉科杂志, 2000; 35 (3):196-199. 46． 邹静*，毕爱芳，吴兴辰，李振彬，杨伟炎. 用一种新方法筛选自身免疫性疾病患者抗内耳抗体. 中华耳鼻咽喉科杂志, 2000; 35 (2): 113-116. 47． 邹静*. 外加电场固定液相分子快速斑点免疫分析. 免疫学杂志, 2000; 16 (4):376-379. 48． 毕爱芳 邹静* 周永青 尚耀东 赵区生. 实验性急性化脓性中耳炎中耳粘膜热休克蛋白的表达. 临床耳鼻咽喉杂志. 2000；14(4): 173-4. 49． 尚耀东*, 邹静, 赵国庆, 汤晓义, 陶振峰, 吴彦桥. 双侧声带膜样部后1/3切除术治疗双侧外展麻痹.  临床耳鼻咽喉科杂志. 2000; 14(1): 35-36. 50． 周永青, 邹静*, 尚耀东, 毕爱芳. 中耳肺炎克雷伯杆菌感染诱导的急性期HSP70相关反应的定位观察. 免疫学杂志 2000; 16(4): 317. 51． 邹静*. 硝酸纤维素膜微粒ELISA方法的建立. 免疫学杂志, 1999;15(2):143. 52． 毕爱芳*, 邹静, 周永青, 赵区生, 谭巨莲. 变形杆菌引起实验小鼠菌血症成批死亡报告. 实验动物学1999; 16(3): 27-29. 53． 毕爱芳, 邹静*, 周永青, 尚耀东. 预防喉癌术后咽瘘的一种新方法——自体纤维蛋白的制作和应用.  北京军区医药, 1999 Feb 15;  1: 38-39. 54． 邹静*，吴兴辰. 听神经瘤的病因、发病机理和遗传学. 国外医学耳鼻咽喉科学分册 1998; 22(3): 155-159. 55． 邹静*，姜泗长，周永青，尚耀东，毕爱芳. 实验性急性中耳细菌感染诱发的热休克反应. 中华耳鼻咽喉科杂志, 1998; 33(5): 282-284. 56． 邹静*，尚耀东，毕爱芳，赵国庆，高兰英. 喉癌组织中p53 蛋白和HPV E6蛋白复合物的观测. 临床耳鼻咽喉科杂志 1998; 12(2): 84. 57． 邹静*. 硝酸纤维素膜微粒ELISA方法的建立. 免疫学杂志, 1999;15(2):143. 58． 邹静*, 周永青, 毕爱芳, 肺炎克雷伯杆菌感染诱导豚鼠内耳产生热休克反应的分析(简报). 中华微生物学和免疫学杂志1998; 18(6) . 59． 邹静*，姜泗长，顾瑞，杨伟炎. 斑点亲和纯化法一种用于纯化由微量混合抗原产生抗体的方法. 免疫学杂志,  1997;13(4):278. 60． 吴兴辰，邹静*，徐铮，李斌，毕爱芳，游国雄. 大鼠额叶皮层局灶毁损对脾细胞增殖的影响. 免疫学杂志,  1997;13(3):173. 61． 吴兴辰, 邹静*. 精神神经内分泌免疫调节的研究进展. 国外医学.神经病学神经外科学分册，1997 Dec 10;  6: 286-289. 62． 时利*，吴彦桥，时文杰，邹静，徐铮，修贺明，成继民，尚耀东，彭子成*，毕爱芳. 实验性犬侧颅底骨缺损修复材料的研究. 中华耳鼻咽喉科杂志, 1997; 32(2): 95-98. 63． 邹静*，尚耀东，彭子成，陶振峰，毕爱芳，高兰瑛. 喉部鳞状细胞癌组织中p53蛋白的免疫转印分析. 耳鼻咽喉头颈外科,1997;4(4):224-227. 64． 邹静*，尚耀东，毕爱芳，马宏敏，赵国庆，高兰瑛. 自体纤维蛋白防止喉癌术后咽瘘的初步探讨. 耳鼻咽喉头颈外科, 1997; 4(3):186-187. 65． 顾瑞*，邹静， 于黎民.  自身免疫性感音神经性聋的听力测试. 中华耳鼻咽喉科杂志, 1995;30(1):20-22. 66． 邹静*，姜泗长，顾瑞，顾之燕. 自身免疫性感音神经性聋血清抗膜迷路蛋白抗体的检测. 中华耳鼻咽喉科杂志, 1995;30(3):154-6. 67． 邹静*，翟所强，姜泗长，顾瑞. 豚鼠膜迷路蛋白抗原性分析. 中华耳鼻咽喉科杂志, 1995;30(1):13-6. 68． 邹静*，翟所强，王沛英，姜泗长，顾瑞，顾之燕. 豚鼠膜迷路蛋白组成分析及免疫转印法检测感音神经性聋患者抗68KD抗体. 中华耳鼻咽喉科杂志, 1994; 29(1):19-22. 69． 翟所强*，邹静，王沛英，姜泗长，顾瑞，顾之燕.  自身免疫性内耳病抗内耳组织相关抗体检测及临床观察. 中华耳鼻咽喉科杂志, 1993; 28(6): 353-355. 70． 邹静*，何凌汉. 人胎盘中Ⅴ型胶原的提取与纯化. 第三军医大学学报, 1992; 14(3):280-282. 71． 邹静*，周定蓉，徐伟恒，甘永莲，何凌汉. Meniere病免疫损伤机理的初步探讨. 中华耳鼻咽喉科杂志, 1992;27(1):14-16.